Close Menu

NEW YORK (GenomeWeb) – Danaher today reported that total sales for the second quarter rose 10 percent year over year and beat the consensus Wall Street estimate. 

For the three months ending June 29, the Washington, DC-based conglomerate posted $4.98 billion in sales, up from $4.51 billion in Q2 2017. Analysts' average sales estimate was $4.92 billion. 

Organically, sales were up 6 percent year over year. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.